ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: GAO Reopens Clinical Center Controversy On Patient Care Payment; NIH Still Resists

January 6, 1978

Low Percentage Of Trials Published In Medical Journals

October 31, 2008

More Oncopathology Research Asked

June 30, 1978

Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA.

November 22, 2006

Construction, Senior Biomedical Service Not In Legislation

November 4, 1988

Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center

March 5, 1999